Shih-Min A. Huang
Novartis (China)(CN)Novartis (United States)(US)Taiwan Semiconductor Manufacturing Company (China)(CN)Taiwan Semiconductor Manufacturing Company (Taiwan)(TW)
Publications by Year
Research Areas
Monoclonal and Polyclonal Antibodies Research, Nanoparticle-Based Drug Delivery, Radiopharmaceutical Chemistry and Applications, Cancer Immunotherapy and Biomarkers, MicroRNA in disease regulation
Most-Cited Works
- → RNF146 is a poly(ADP-ribose)-directed E3 ligase that regulates axin degradation and Wnt signalling(2011)431 cited
- → A transcriptional MAPK Pathway Activity Score (MPAS) is a clinically relevant biomarker in multiple cancer types(2018)210 cited
- → Down Regulation of the Interleukin-8 Promoter by Human Papillomavirus Type 16 E6 and E7 through Effects on CREB Binding Protein/p300 and P/CAF(2002)176 cited
- → Chemical Genetics–Based Target Identification in Drug Discovery(2011)119 cited
- → Deubiquitinase FAM/USP9X Interacts with the E3 Ubiquitin Ligase SMURF1 Protein and Protects It from Ligase Activity-dependent Self-degradation(2012)111 cited
- → Acetylation regulates the differentiation‐specific functions of the retinoblastoma protein(2004)104 cited